T regulatory cells control susceptibility to invasive pneumococcal pneumonia in mice.
T regulatory cells control susceptibility to invasive pneumococcal pneumonia in mice.
复制标题
DOI:
10.1371/journal.ppat.1002660
复制
发表时间:
2012
期刊:
影响因子:
6.7
通讯作者:
Andrew PW
中科院分区:
文献类型:
--
作者:
Neill DR;Fernandes VE;Wisby L;Haynes AR;Ferreira DM;Laher A;Strickland N;Gordon SB;Denny P;Kadioglu A;Andrew PW
Streptococcus pneumoniae is an important human pathogen responsible for a spectrum of diseases including pneumonia. Immunological and pro-inflammatory processes induced in the lung during pneumococcal infection are well documented, but little is known about the role played by immunoregulatory cells and cytokines in the control of such responses. We demonstrate considerable differences in the immunomodulatory cytokine transforming growth factor (TGF)-β between the pneumococcal pneumonia resistant BALB/c and susceptible CBA/Ca mouse strains. Immunohistochemistry and flow cytometry reveal higher levels of TGF-β protein in BALB/c lungs during pneumococcal pneumonia that correlates with a rapid rise in lung Foxp3+Helios+ T regulatory cells. These cells have protective functions during pneumococcal pneumonia, because blocking their induction with an inhibitor of TGF-β impairs BALB/c resistance to infection and aids bacterial dissemination from lungs. Conversely, adoptive transfer of T regulatory cells to CBA/Ca mice, prior to infection, prolongs survival and decreases bacterial dissemination from lungs to blood. Importantly, strong T regulatory cell responses also correlate with disease-resistance in outbred MF1 mice, confirming the importance of immunoregulatory cells in controlling protective responses to the pneumococcus. This study provides exciting new evidence for the importance of immunomodulation during pulmonary pneumococcal infection and suggests that TGF-β signalling is a potential target for immunotherapy or drug design. Streptococcus pneumoniae is a major human bacterial pathogen that causes a wide range of diseases including pneumonia, meningitis, sepsis and ear infections. The bacterium is responsible for around 1.2 million deaths per year, mostly in high-risk groups such as children, the elderly and those with a weakened immune system. Infection with the pneumococcus can induce a wide-variety of immune responses and disease symptoms and it is not known why some people are more resistant to infection than others. Here, we identify an important role in natural resistance against pneumococcal pneumonia for a group of cells – known as T regulatory cells – that control the immune response to pneumococcal infection. In mice, strong T regulatory cell responses correlate with resistance to invasive pneumococcal pneumonia. Disease-resistance can be boosted by administering T regulatory cells to highly susceptible mice or inhibited by blocking the activity of these cells in resistant mice. These results advance our understanding of the host immunity differences that underpin resistance to pneumococcal pneumonia and offer hope that in the future we might boost resistance in susceptible individuals through modulation of their immune system.
登录
查看更多内容
影响因子:
3.7
作者:
Akimova T;Beier UH;Wang L;Levine MH;Hancock WW
通讯作者:
Hancock WW
影响因子:
3.1
作者:
Kadioglu, A;Gingles, NA;Andrew, PW
通讯作者:
Andrew, PW
影响因子:
6.7
作者:
Buttery, J;Moxon, ER
通讯作者:
Moxon, ER
影响因子:
14.8
作者:
Fantini, Massimo C.;Dominitzki, Sabine;Becker, Christoph
通讯作者:
Becker, Christoph
DOI:
10.1164/ajrccm.160.supplement_1.4
发表时间:
1999-11-01
影响因子:
24.7
作者:
Haslett, C
通讯作者:
Haslett, C